Article Versions Notes

Tachiiri T, Nishiofuku H, Maeda S, Sato T, Toyoda S, Matsumoto T, Chanoki Y, Minamiguchi K, Taiji R, Kunichika H, et al. Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma. Current Oncology. 2023; 30(5):4779-4786. https://doi.org/10.3390/curroncol30050360

Tachiiri, Tetsuya, Hideyuki Nishiofuku, Shinsaku Maeda, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Kiyoyuki Minamiguchi, Ryosuke Taiji, Hideki Kunichika, and et al. 2023. "Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma" Current Oncology 30, no. 5: 4779-4786. https://doi.org/10.3390/curroncol30050360

Tachiiri, T., Nishiofuku, H., Maeda, S., Sato, T., Toyoda, S., Matsumoto, T., Chanoki, Y., Minamiguchi, K., Taiji, R., Kunichika, H., Yamauchi, S., Ito, T., Marugami, N., & Tanaka, T. (2023). Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma. Current Oncology, 30(5), 4779-4786. https://doi.org/10.3390/curroncol30050360